Meletios A. Dimopoulos, MD

Professor and Chairman
Department of Clinical Therapeutics
National and Kapodistrian University of Athens School of Medicine
Athens, Greece

Dr. Meletios Dimopoulos received his medical degree from the National and Kapodistrian University of Athens, Greece. He completed a residency in internal medicine at the Royal Victoria Hospital, McGill University, Montreal, Canada, and a fellowship in hematology/oncology at the University of Texas MD Anderson Cancer Center, Houston. Dr. Dimopoulos is Professor and Chairman of the Department of Clinical Therapeutics at the National and Kapodistrian University of Athens School of Medicine; he was also elected dean of the medical school and rector of the university.

Currently, Dr. Dimopoulos is the chairman of the Greek Myeloma Study Group and of the Balkan Myeloma Study Group. He serves on the scientific advisory boards of the International Myeloma Foundation and the International Waldenström’s Macroglobulinemia Foundation, and is a board member of the European Myeloma Network. He has authored more than 931 publications in peer-reviewed journals, as well as numerous abstracts and several textbook chapters primarily focusing on plasma cell dyscrasias, and genitourinary and gynecologic cancers. In addition, Dr. Dimopoulos is a journal reviewer for The New England Journal of Medicine, Blood, Journal of Clinical Oncology, Haematologica, Leukemia, Cancer, European Journal of Haematology, and Leukemia and Lymphoma. He is also associate editor of Current Hematologic Malignancy Reports, and is an editorial board member of Haematologica, Leukemia and Lymphoma, Clinical Lymphoma and Myeloma, Expert Review of Hematology and Blood Advances.

Dr. Dimopoulos is a recent recipient of Waldenström’s award for Myeloma Research of the International Myeloma Society and the CoMy Excellence Award. In May 2018 he was elected as foreign associate member of the National Academy of Medicine of France.

Last modified: March 23, 2021